These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 11214198)

  • 1. Treatment of human brucellosis.
    Solera J
    J Med Liban; 2000; 48(4):255-63. PubMed ID: 11214198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition and optimum treatment of brucellosis.
    Solera J; Martínez-Alfaro E; Espinosa A
    Drugs; 1997 Feb; 53(2):245-56. PubMed ID: 9028744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A comparative therapeutic and multicenter trial of rifampicin and doxycycline versus streptomycin and doxycycline in human brucellosis].
    Solera J; Medrano F; Rodríguez M; Geijo P; Paulino J
    Med Clin (Barc); 1991 May; 96(17):649-53. PubMed ID: 1905372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of gentamicin plus doxycycline versus streptomycin plus doxycycline in the treatment of brucellosis in humans.
    Hasanjani Roushan MR; Mohraz M; Hajiahmadi M; Ramzani A; Valayati AA
    Clin Infect Dis; 2006 Apr; 42(8):1075-80. PubMed ID: 16575723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between doxycycline-rifampin-amikacin and doxycycline-rifampin regimens in the treatment of brucellosis.
    Ranjbar M; Keramat F; Mamani M; Kia AR; Khalilian FO; Hashemi SH; Nojomi M
    Int J Infect Dis; 2007 Mar; 11(2):152-6. PubMed ID: 16798042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter therapeutic study of 1100 children with brucellosis.
    Lubani MM; Dudin KI; Sharda DC; Ndhar DS; Araj GF; Hafez HA; al-Saleh QA; Helin I; Salhi MM
    Pediatr Infect Dis J; 1989 Feb; 8(2):75-8. PubMed ID: 2649867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy of gentamicin for 5 days plus doxycycline for 8 weeks versus streptomycin for 2 weeks plus doxycycline for 45 days in the treatment of human brucellosis: a randomized clinical trial.
    Roushan MR; Amiri MJ; Janmohammadi N; Hadad MS; Javanian M; Baiani M; Bijani A
    J Antimicrob Chemother; 2010 May; 65(5):1028-35. PubMed ID: 20215128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of human brucellosis with rifampicin].
    Godeau P; Fuchs G; Guillevin L; Philippon A; Tucat G; Cabane J; Herson S
    Sem Hop; 1984 Jan; 60(1):5-9. PubMed ID: 6320435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxycycline-rifampin versus doxycycline-rifampin-gentamicin in treatment of human brucellosis.
    Mile B; Valerija K; Krsto G; Ivan V; Ilir D; Nikola L
    Trop Doct; 2012 Jan; 42(1):13-7. PubMed ID: 22290107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of doxycycline-streptomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial.
    Hashemi SH; Gachkar L; Keramat F; Mamani M; Hajilooi M; Janbakhsh A; Majzoobi MM; Mahjub H
    Int J Infect Dis; 2012 Apr; 16(4):e247-51. PubMed ID: 22296864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of acute brucellosis with cotrimoxazole, doxicyclin and streptomycin. A comparative study (author's transl)].
    Vargas V; Pedreira JD; Clotet B; Juste C; Guardia J; Bacardi R
    Med Clin (Barc); 1980 Dec; 75(10):418-20. PubMed ID: 7007755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic options for human brucellosis.
    Al-Tawfiq JA
    Expert Rev Anti Infect Ther; 2008 Feb; 6(1):109-20. PubMed ID: 18251668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three different combination therapies in the treatment of human brucellosis.
    Ersoy Y; Sonmez E; Tevfik MR; But AD
    Trop Doct; 2005 Oct; 35(4):210-2. PubMed ID: 16354469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on brucellosis: therapeutic challenges.
    Solera J
    Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S18-20. PubMed ID: 20692127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of two regimens in the treatment of brucellosis.
    Rodriguez Zapata M; Gamo Herranz A; De La Morena Fernández J
    Chemioterapia; 1987 Jun; 6(2 Suppl):360-2. PubMed ID: 3334575
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative trial of doxycycline plus streptomycin versus doxycycline plus rifampin for the therapy of human brucellosis.
    Colmenero Castillo JD; Hernandez Marquez S; Reguera Iglesias JM; Cabrera Franquelo F; Rius Diaz F; Alonso A
    Chemotherapy; 1989; 35(2):146-52. PubMed ID: 2667903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative trial of three therapeutic regimens: ciprofloxacin-rifampin, ciprofloxacin-doxycycline and doxycycline-rifampin in the treatment of brucellosis.
    Keramat F; Ranjbar M; Mamani M; Hashemi SH; Zeraati F
    Trop Doct; 2009 Oct; 39(4):207-10. PubMed ID: 19762571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas.
    Solera J; Rodríguez-Zapata M; Geijo P; Largo J; Paulino J; Sáez L; Martínez-Alfaro E; Sánchez L; Sepulveda MA; Ruiz-Ribó MD
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2061-7. PubMed ID: 8540716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brucellosis.
    Pappas G; Akritidis N; Bosilkovski M; Tsianos E
    N Engl J Med; 2005 Jun; 352(22):2325-36. PubMed ID: 15930423
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of primary invasion acute brucellosis in its septicemic form with doxycycline].
    Micoud M; Stahl JP
    Nouv Presse Med; 1980 Jan; 9(21 Suppl):120-1. PubMed ID: 7355080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.